The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

PBMs disputed those findings. President-elect Donald Trump has declared his intention to target drug middlemen practices, though he hasn't offered detailed policy proposals. He nominated a ...

But for all the noise, many Wall Street professionals believe the policy risk in the healthcare sector is lower than feared. ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

He added that the law fails to "rein in abusive practices" from drug-pricing middlemen called pharmacy benefit managers and ...

Denouncing the $557 billion industry as “horrible middlemen,” responsible for—and “rich as hell” from— America’s incomparably high prescription drug prices, Trump vowed to get rid of ...